U.S. Healthcare Finance Solutions Market Size, Share & Trends Analysis Report By Equipment Type, By Healthcare Facility Type, By Services, By Lenders (Government & Other Federal Agencies, Private Players), And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. healthcare finance solutions market size was estimated at USD 51.31 billion in 2022 and is expected to surpass around USD 108.75 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 7.8% during the forecast period 2023 to 2032.

U.S. Healthcare Finance Solutions Market Size, 2023 to 2032

Key Takeaways:

  • The decontamination equipment segment dominated the U.S. healthcare finance solutions market with a 37.9% revenue share in 2022
  • The hospital & health systems were the largest segment in 2022 accounting for 26.9% of the market share owing
  • The private player's segment contributed to the largest market share accounting for 53.2% of the share in 2022
  • Based on services, the equipment and technology finance segment accounted for the largest market share of 46.2% in 2022.
  • In equipment and technology finance, the private players segment dominated the market with a share of 52.0% in 2022 and is likely to grow at a CAGR of 7.5% during the forecast period.

U.S. Healthcare Finance Solutions Market Report Scope

Report Coverage Details
Market Size in 2023 USD 55.32 Billion
Market Size by 2032 USD 108.75 Billion
Growth Rate From 2023 to 2032 CAGR of 7.8%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Equipment Type, Healthcare facility type, Services, lenders
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled Siemens Financial Services, Inc.; General Electric Company; Commerce Bankshares, Inc.; Thermo Fisher Scientific, Inc.; Siena Healthcare Finance; CIT Group, Inc.; Stryker; Gemino Healthcare Finance; Oxford Finance LLC; TCF Capital Solutions

 

The COVID-19 pandemic had an unprecedented impact on the healthcare business in 2020. The rising need for medical equipment and tools and hi-tech infrastructure to provide better quality services to patients were the primary market growth drivers. The rising number of admissions to healthcare facilities due to chronic diseases, aging population, and disability is driving the growth of healthcare expenditure in the country.

The coronavirus pandemic negatively impacted the finance solutions market initially as the companies had to work remotely to operate the business. However, the U.S. healthcare finance solutions market responded well to the outbreak and seized the opportunity, as the demand for funds increased by the healthcare providers to provide medical services. The COVID-19 pandemic has increased the number of admissions in the healthcare facilities which resulted in better healthcare facilities, high-quality treatment, and the requirement of medical equipment to fulfill the demands of the patients.

Healthcare in the U.S. is more expensive than in any other country. The health care spending per person in the U.S. was USD 10,966 in 2019. This can be attributed to advancements in treatment, healthcare tools, or equipment and the development of advanced healthcare infrastructure. Healthcare providers continue to participate in various value-based care models that drive clinical integration and financial risk based on performance.

Digitalization has helped healthcare providers deal with the challenges of the pandemic and improve patient outcomes. Digital technology is likely to grow the healthcare business. For instance, Siemens Financial Services is helping in removing barriers to investment and helping the healthcare sector and providers secure the equipment, technology, and facilities needed to provide better services to the patients.

The healthcare industry is evolving with the rising adoption of technologically advanced products for enhancing functions and processes. Advancements can be observed in healthcare equipment, software, infrastructure, and therapy, among others. Safe and effective therapy or treatment is a primary concern of every healthcare provider, and technological advancements make it easy to achieve this goal.

The U.S. is one of the leading countries to manufacture and develop technologically advanced products for the healthcare industry, which is increasing the total cost of healthcare for patients. This is directly increasing the financial burden on patients. New medical technology is responsible for a 40% to 50% increase in annual healthcare costs.

Health insurance and finance solutions companies provide payment for innovations, such as advanced therapy, and medical services from advanced healthcare providers, as medical treatments can be very expensive and their cost would be beyond the reach of many people unless they are covered by healthcare insurance schemes.

Equipment Type Insights

The decontamination equipment segment dominated the U.S. healthcare finance solutions market with a 37.9% revenue share in 2022 as there is a high requirement for the equipment and they are costly and need huge capital investment. The COVID-19 pandemic has boosted the diagnostic area for the detection and testing of the virus which increased the demand for diagnostic kits and other diagnostic equipment.

Based on equipment, the market is segmented into diagnostic/imaging equipment, specialty beds, surgical instruments, decontamination equipment, and IT equipment. The specialty beds segment is anticipated to grow at the fastest CAGR of 9.2% over the forecast period. This is due to the increase in demand for advanced beds in the healthcare facilities and the development of healthcare infrastructure is expected to fuel this industry’s growth over the forecast period.

Healthcare Facility Type Insights

The hospital & health systems were the largest segment in 2022 accounting for 26.9% of the market share owing to the increasing number of hospitals & health systems along with their increasing demand for medical care. Among frequently changing laws, expansion of healthcare access, and increasing patient admission, hospitals need financial support. Simultaneously, healthcare facilities are expected to offer the most appropriate care and the most desired outcomes to the patients. Hence, the segment is anticipated to witness significant growth over the forecast period.

The outpatient surgery center is another highly driven healthcare facility. Outpatient imaging centers are medical facilities providing imaging services. These imaging centers use advanced techniques and high-tech equipment to generate accurate images of organs, soft tissues, and blood vessels, among others. Outpatient imaging centers are expected to grow at the fastest rate of 9.1% over the forecast period due to increasing investments in R&D for developing innovative technology and the growing incidence of chronic diseases in the country.

Lenders Insights

The private player's segment contributed to the largest market share accounting for 53.2% of the share in 2022 This can be attributed to the fast approval and cash disbursement process by the private players. Based on lenders, the U.S. market is segmented into government and other federal agencies, private players, and others (such as patients).

The traditional methods of financing solutions involve endless paperwork and manual document collection are time-consuming processes that caused delays in the loan disbursement. In today’s world, with the help of AI-based platforms, the process is fast, paperless, and provides flexibility to design financial solutions and orchestration of responsibilities and communications.

Services Insights

Based on services, the equipment and technology finance segment accounted for the largest market share of 46.2% in 2022. This is due to the huge capital required for the setup along with the costly healthcare equipment which requires financial support. Financial solutions companies work closely with the business sector to fulfill the long-term financial requirements of the sector. Finance companies provide various benefits to their clients such as tax benefits, flexible payment terms, and no depreciation.

The finance companies provide various benefits to their clients such as tax benefits, flexible payment terms, no deprecation, etc. These companies use financial expertise and digitalization to provide financial solutions to serve the equipment & technology need of the healthcare sector which is likely to result in smooth functioning of the business operations.

The report also provides a crisscross analysis of lenders and service side segments for analyzing the share of lenders in each service type. In equipment and technology finance, the private players segment dominated the market with a share of 52.0% in 2022 and is likely to grow at a CAGR of 7.5% during the forecast period. The majority of the private finance companies offer equipment and technology finance to healthcare providers, which is a major factor driving the market growth.

Recent developments:

  • In September 2021, Siena Healthcare Finance recently provided a USD 12.0 million working capital facility for a private equity-backed multi-state provider of specialty pharmaceutical, infusion, and nutritional therapy services for patients with chronic disease and health issues
  • In April 2021, CIT Group collaborated with iCleanse to provide low-interest financing on all iCleanse disinfection products to keep customers and staff safe from infectious pathogens
  • In April 2021, Commerce Bankshare, Inc. has joined Guidewire PartnerConnect as a solution partner. The partnership is likely to enable insurers to provide single- and multi-party electronic claims payments

Some prominent players in the U.S. healthcare finance solutions market include:

  • Siemens Financial Services, Inc.
  • General Electric Company
  • Commerce Bankshares, Inc.
  • Thermo Fisher Scientific, Inc.
  • Siena Healthcare Finance
  • CIT Group, Inc.
  • Stryker
  • Gemino Healthcare Finance
  • Oxford Finance LLC
  • TCF Capital Solutions

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Healthcare Finance Solutions market.

By Equipment Type 

  • Diagnostic/Imaging Equipment
  • Specialist Beds
  • Surgical Instruments
  • Decontamination Equipment
  • IT Equipment

By Healthcare Facility Type 

  • Hospitals & Health Systems
  • Outpatient Imaging Centers
  • Outpatient Surgery Centers
  • Physician Practices & Outpatient Clinics
  • Diagnostic Laboratories
  • Urgent Care Clinics
  • Skilled Nursing Facilities
  • Pharmacies

By Services 

    • Equipment & Technology Finance
      • Government & Other Federal Agencies
      • Private Players
      • Others
    • Working Capital Finance
      • Government & Other Federal Agencies
      • Private Players
      • Others
    • Project Finance Solutions
      • Government & Other Federal Agencies
      • Private Players
      • Others
    • Corporate Lending
      • Government & Other Federal Agencies
      • Private Players
      • Others

By Lenders 

  • Government & Other Federal Agencies
  • Private Players
  • Others

Frequently Asked Questions

The U.S. healthcare finance solutions market size was estimated at USD 51.31 billion in 2022 and is expected to surpass around USD 108.75 billion by 2032

The U.S. healthcare finance solutions market is expected to grow at a compound annual growth rate of 7.8% from 2023 to 2032

Some key players operating in the U.S. healthcare finance solutions market include Siemens Financial Services, Inc. General Electric Company, Commerce Bankshares, Inc., Thermo Fisher Scientific, Inc., Siena Healthcare Finance, CIT Group, Inc., Stryker, Gemino Healthcare Finance, Oxford Finance LLC, TCF Capital Solutions.

Key factors that are driving the market growth include rising need of medical equipment and tools and increasing required of hi-tech technology and infrastructure to provide better quality services to the patients.

Chapter 1. Research Methodology
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 Nova one advisor’s internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing
Chapter 2. Executive Summary
                   2.1 U.S. Healthcare Finance Solutions Market Outlook, 2020 - 2032
Chapter 3. Industry Outlook: Market Variables, Trends, & Scope
                   3.1 Market Disruption
                       3.1.1 Transition of the delivery model (volume to value-based healthcare provision
                       3.1.2 Medicaid reimbursement
                       3.1.3 Technological advancements & administration expenditures
                       3.1.4 Potential strategies being adopted
                       3.1.5 Digital finance disruption
                   3.2 Correlation of Demand and Supply (Total Addressable Market (TAM) and SOM)
                       3.2.1 % Demand achieved
                       3.2.2 Demand V/S Supply, by states
                   3.3 COVID-19 impact
Chapter 4. U.S. Healthcare Finance Solutions Market: Equipment Type Estimates & Trend Analysis
                   4.1 U.S Healthcare Finance Solutions Market: Equipment Type Movement Analysis
                   4.2 Diagnostic/Imaging Equipment
                       4.2.1 Diagnostic/imaging equipment market, 2020 - 2032
                   4.3 Specialist Beds
                       4.3.1 Specialist beds market, 2020 - 2032
                   4.4 Surgical Instruments
                       4.4.1 Surgical instruments market, 2020 - 2032
                   4.5 Decontamination Equipment
                       4.5.1 Decontamination equipment market, 2020 - 2032
                   4.6 IT Equipment
                       4.6.1 IT equipment market, 2020 - 2032
Chapter 5. U.S Healthcare Finance Solutions Market: Healthcare Facility Type Estimates & Trend Analysis
                   5.1 U.S. Healthcare Finance Solutions Market: Healthcare Facility Type Movement Analysis
                   5.2 Hospitals & Health Systems
                       5.2.1 Hospitals & health systems market, 2020 - 2032
                   5.3 Outpatient Imaging Centers
                       5.3.1 Outpatient imaging centers market, 2020 - 2032
                   5.4 Outpatient Surgery Centers
                       5.4.1 Outpatient surgery centers market, 2020 - 2032
                   5.5 Physicians Practices & Outpatient Clinics
                       5.5.1 Physicians practices & outpatient clinics market, 2020 - 2032
                   5.6 Diagnostic Laboratories
                       5.6.1 Diagnostic laboratories market, 2020 - 2032
                   5.7 Urgent Care Clinics
                       5.7.1 Urgent care clinics market, 2020 - 2032
                   5.8 Skilled Nursing Facilities
                       5.8.1 Skilled nursing facilities market, 2020 - 2032
                   5.9 Pharmacies
                       5.9.1 Pharmacies market, 2020 - 2032
                   5.10 Other Healthcare Providers
                       5.10.1 Other healthcare providers market, 2020 - 2032
Chapter 6. U.S. Healthcare Finance Solutions Market: Services Estimates & Trend Analysis
                   6.1 U.S. Healthcare Finance Solutions Market: Services Movement Analysis
                   6.2 Equipment and Technology Finance
                       6.2.1 Equipment and technology finance market, 2020 - 2032
                           6.2.1.1 Government & Other Federal Agencies
                           6.2.1.2 Private Players
                           6.2.1.3 Others
                   6.3 Working Capital Finance
                       6.3.1 Working capital finance market, 2020 - 2032
                           6.3.1.1 Government & Other Federal Agencies
                           6.3.1.2 Private Players
                           6.3.1.3 Others
                   6.4 Project Finance Solutions
                       6.4.1 Project finance solutions market, 2020 - 2032
                           6.4.1.1 Government & Other Federal Agencies
                           6.4.1.2 Private Players
                           6.4.1.3 Others
                   6.5 Corporate Lending
                       6.5.1 Corporate lending market, 2020 - 2032
                           6.5.1.1 Government & Other Federal Agencies
                           6.5.1.2 Private Players
                           6.5.1.3 Others
Chapter 7. U.S. Healthcare Finance Solutions Market: Lenders Estimates & Trend Analysis, by Service, Source, & Product
                   7.1 U.S. Healthcare Finance Solutions Market Share By Lenders Movement Analysis
                   7.2 Government & Other Federal Agencies
                       7.2.1 Government & other federal agencies market, 2020 - 2032
                   7.3 Private Players
                       7.3.1 Private players market, 2020 - 2032
                   7.4 Others
                       7.4.1 Others market, 2020 - 2032
Chapter 8. Competitive Landscape
                   8.1 Company Profiles
                       8.1.1 Siemens Financial Services, Inc.
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 General Electric Company
                           8.1.2.1 Company overview
                           8.1.2.2 Financial performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 Commerce Bankshares, Inc.
                           8.1.3.1 Company overview
                           8.1.3.2 Financial performance
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 Thermo Fisher Scientific, Inc.
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 Siena Healthcare Finance
                           8.1.5.1 Company overview
                           8.1.5.2 Financial performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 CIT Group, Inc.
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 Stryker
                           8.1.7.1 Company overview
                           8.1.7.2 Financial performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 Germino Healthcare Finance
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 Oxford Finance LLC
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiatives
                       8.1.10 TCF Capital Solutions
                           8.1.10.1 Company overview
                           8.1.10.2 Financial performance
                           8.1.10.3 Product benchmarking
                           8.1.10.4 Strategic initiatives

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers